CorMedix Announces Collaboration for DefenCath Promotion to the VA and Other Federal Facilities
(NasdaqGM:CRMD), BERKELEY HEIGHTS, N.J., Jan. 21, 2025 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announces it has engaged with WSI PBG, a subsidiary of Golden State Medical Supply, to promote DefenCath(R) to healthcare providers in facilities operated by the […]